Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects
Recent data reinforce the anti-fibrotic activity of Aramchol previously observed in a wide range of pre-clinical models, in addition to the known effects in...
Source: prnewswire.com